UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 56

Sortiert nach

Selective Estrogen Receptor Modulators: An Update on Recent Clinical Findings

Obstetrical & gynecological survey, 2008-03, Vol.63 (3), p.163-181

2008

Link zum Volltext

Verfügbarkeit prüfen

Antiresorptive Treatment of Postmenopausal Osteoporosis: Comparison of Study Designs and Outcomes in Large Clinical Trials with Fracture as an Endpoint

Endocrine reviews, 2002-02, Vol.23 (1), p.16-37

2002

Link zum Volltext

Verfügbarkeit prüfen

Skeletal Effects of Raloxifene After 8 Years: Results from the Continuing Outcomes Relevant to Evista (CORE) Study

Journal of bone and mineral research, 2005-09, Vol.20 (9), p.1514-1524

2005

Link zum Volltext

Verfügbarkeit prüfen

Assessment of regional changes in skeletal metabolism following 3 and 18 months of teriparatide treatment

Journal of bone and mineral research, 2010-05, Vol.25 (5), p.960-967

2010

Link zum Volltext

Verfügbarkeit prüfen

Baseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosis

Journal of rheumatology, 2010-01, Vol.37 (1), p.141

2010

Link zum Volltext

Verfügbarkeit prüfen

The effects of combined raloxifene and oral estrogen on vasomotor symptoms and endometrial safety

Menopause (New York, N.Y.), 2007-05, Vol.14 (3 Pt 1), p.510

2007

Link zum Volltext

Verfügbarkeit prüfen

A comparison of the effects of raloxifene and estrogen on bone in postmenopausal women

The journal of clinical endocrinology and metabolism, 2000-06, Vol.85 (6), p.2197-2202

2000

Link zum Volltext

Verfügbarkeit prüfen

Cyr61, Product of a Growth Factor-Inducible Immediate-Early Gene, Regulates Chondrogenesis in Mouse Limb Bud Mesenchymal Cells

Developmental biology, 1997-12, Vol.192 (2), p.492-508

1997

Link zum Volltext

Verfügbarkeit prüfen

Raloxifene and estrogen effects on quality of life in healthy postmenopausal women: a placebo-controlled randomized trial

Obstetrics and gynecology (New York. 1953), 2000-09, Vol.96 (3), p.359-365

2000

Link zum Volltext

Verfügbarkeit prüfen

Hand Dominance and Bone Microarchitecture at the Distal Radius by High-Resolution Magnetic Resonance Imaging - Updated Data

Journal of clinical densitometry, 2010, Vol.13 (1), p.115-115

2010

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Raloxifene 60 Milligrams/Day in Postmenopausal Asian Women

The journal of clinical endocrinology and metabolism, 2003-07, Vol.88 (7), p.3130-3136

2003

Link zum Volltext

Verfügbarkeit prüfen

Abstract #265: Trends of Incident and Prevalent use of Human Regular U-500 Insulin Over A 9-Year Period in the United States

Endocrine practice, 2015-05, Vol.21, p.56-57

2015

Link zum Volltext

Verfügbarkeit prüfen

Selective Estrogen Receptor Modulators: An Update on Recent Clinical Findings

Obstetrical & gynecological survey, 2008-03, Vol.63 (3), p.163-181

2008

Link zum Volltext

Verfügbarkeit prüfen

Identifying insulin treatment responders with a composite measure: beyond Hba1c < 7% in patients with type 2 diabetes

Current medical research and opinion, 2018-02, Vol.34 (2), p.329-336

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract #269: Pharmacokinetic Bioequivalent and Non-Bioequivalent Concentrated Insulin Formulations: Implications for Clinical use and Dosing

Endocrine practice, 2015-05, Vol.21, p.59

2015

Link zum Volltext

Verfügbarkeit prüfen

Ease of use of two reusable, half-unit increment dosing insulin pens by adult caregivers of children with type 1 diabetes: a randomized, crossover comparison

Journal of diabetes science and technology, 2013-03, Vol.7 (2), p.582-583

2013

Link zum Volltext

Verfügbarkeit prüfen

Relationships Between Bone Mineral Density and Incident Vertebral Fracture Risk with Raloxifene Therapy

Journal of bone and mineral research, 2002-01, Vol.17 (1), p.1-10

2002

Link zum Volltext

Verfügbarkeit prüfen

The Role of Selective Estrogen Receptor Modulators in the Prevention and Treatment of Osteoporosis

Rheumatic diseases clinics of North America, 2001-02, Vol.27 (1), p.163-185

2001

Link zum Volltext

Verfügbarkeit prüfen

A randomized, cross-over comparison of preference between two reusable insulin pen devices in pen-naïve adults with diabetes

Current medical research and opinion, 2013-05, Vol.29 (5), p.465-473

2013

Link zum Volltext

Verfügbarkeit prüfen

Occurrence of Hypercalciuria in Patients with Osteoporosis Treated with Teriparatide

The journal of clinical endocrinology and metabolism, 2007-09, Vol.92 (9), p.3535-3541

2007

Link zum Volltext

Verfügbarkeit prüfen

Bone formation markers in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate

Bone (New York, N.Y.), 2010-04, Vol.46 (4), p.929-934

2010

Link zum Volltext

Verfügbarkeit prüfen

Vertebral Fracture Risk Is Reduced in Women Who Lose Femoral Neck BMD With Teriparatide Treatment

Journal of bone and mineral research, 2009-06, Vol.24 (6), p.1125-1131

2009

Link zum Volltext

Verfügbarkeit prüfen

Raloxifene and Estrogen Effects on Quality of Life in Healthy Postmenopausal Women: A Placebo-Controlled Randomized Trial

Obstetrics and gynecology (New York. 1953), 2000-09, Vol.96 (3), p.359-365

2000

Link zum Volltext

Verfügbarkeit prüfen

Expectations about insulin therapy, perceived insulin-delivery system social acceptability, and insulin treatment satisfaction contribute to decreases in insulin therapy self-efficacy in patients with type 2 diabetes after 36 weeks insulin therapy (2型糖尿病患者经过36周的胰岛素治疗后，患者对胰岛素治疗的期望、感知的胰岛素给药装置的社会接受性以及对胰岛素治疗的满意度都可以导致胰岛素治疗自我效能感的下降)

Journal of diabetes, 2013-09, Vol.5 (3), p.358-367

2013

Link zum Volltext

Verfügbarkeit prüfen

Comparative effects of raloxifene and alendronate on fracture outcomes in postmenopausal women with low bone mass

Bone (New York, N.Y.), 2007-04, Vol.40 (4), p.843-851

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(48)

Publikationsform

Sprache

Englisch
(56)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(33)
Science & Technology
(33)
Female
(29)
Humans
(29)
Middle Aged
(22)
Endocrinology & Metabolism
(18)
Aged
(17)
Biological And Medical Sciences
(17)
Double-Blind Method
(14)
Medical Sciences
(13)
Raloxifene Hydrochloride - Therapeutic Use
(13)
Osteoporosis, Postmenopausal - Drug Therapy
(12)
Pharmacology. Drug Treatments
(10)
Bone Density - Drug Effects
(9)
Osteoporosis
(9)
Treatment Outcome
(9)
Raloxifene
(8)
Selective Estrogen Receptor Modulators - Therapeutic Use
(8)
Animals
(7)
General & Internal Medicine
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Selective Estrogen Receptor Modulators: An Update on Recent Clinical Findings

Antiresorptive Treatment of Postmenopausal Osteoporosis: Comparison of Study Designs and Outcomes in Large Clinical Trials with Fracture as an Endpoint

Skeletal Effects of Raloxifene After 8 Years: Results from the Continuing Outcomes Relevant to Evista (CORE) Study

Assessment of regional changes in skeletal metabolism following 3 and 18 months of teriparatide treatment

Baseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosis

The effects of combined raloxifene and oral estrogen on vasomotor symptoms and endometrial safety

A comparison of the effects of raloxifene and estrogen on bone in postmenopausal women

Cyr61, Product of a Growth Factor-Inducible Immediate-Early Gene, Regulates Chondrogenesis in Mouse Limb Bud Mesenchymal Cells

Raloxifene and estrogen effects on quality of life in healthy postmenopausal women: a placebo-controlled randomized trial

Hand Dominance and Bone Microarchitecture at the Distal Radius by High-Resolution Magnetic Resonance Imaging - Updated Data

Efficacy and Safety of Raloxifene 60 Milligrams/Day in Postmenopausal Asian Women

Abstract #265: Trends of Incident and Prevalent use of Human Regular U-500 Insulin Over A 9-Year Period in the United States

Selective Estrogen Receptor Modulators: An Update on Recent Clinical Findings

Identifying insulin treatment responders with a composite measure: beyond Hba1c < 7% in patients with type 2 diabetes

Abstract #269: Pharmacokinetic Bioequivalent and Non-Bioequivalent Concentrated Insulin Formulations: Implications for Clinical use and Dosing

Ease of use of two reusable, half-unit increment dosing insulin pens by adult caregivers of children with type 1 diabetes: a randomized, crossover comparison

Relationships Between Bone Mineral Density and Incident Vertebral Fracture Risk with Raloxifene Therapy

The Role of Selective Estrogen Receptor Modulators in the Prevention and Treatment of Osteoporosis

A randomized, cross-over comparison of preference between two reusable insulin pen devices in pen-naïve adults with diabetes

Occurrence of Hypercalciuria in Patients with Osteoporosis Treated with Teriparatide

Bone formation markers in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate

Vertebral Fracture Risk Is Reduced in Women Who Lose Femoral Neck BMD With Teriparatide Treatment

Raloxifene and Estrogen Effects on Quality of Life in Healthy Postmenopausal Women: A Placebo-Controlled Randomized Trial

Comparative effects of raloxifene and alendronate on fracture outcomes in postmenopausal women with low bone mass

Suchergebnisse filtern